vrs37, is it your assumption that everyone except yourself is incompetent? If so, you might like to revisit that self assessment. For instance (and this is critical to everything that is currently underway), have you worked out why Idronoxil is delivered by suppository and why it has a half life >10 hours, compared to 45 minutes when delivered intravenously?
I relish contrarian views, but please use common sense. Was it you who suggested that Covid patients facing imminent death might refuse to be treated via suppositories? And do you really think BMS would agree to supply Opdivo for the IONIC trial without conducting due diligence into Veyonda and Noxopharm? If this is a deal-breaker for you, why don't you ask Noxopharm?
Graham Kelly has cleared himself of terminal cancer and is determined to use the knowledge gained to help others. I trust him, and it appears I am not alone. The SP has risen from 20 cents to 60 cents since your first appearance here.
- Forums
- ASX - By Stock
- NOX
- BMS NOX to partner on pilot study
BMS NOX to partner on pilot study, page-6
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NOX (ASX) to my watchlist
(20min delay)
|
|||||
Last
8.2¢ |
Change
-0.005(5.75%) |
Mkt cap ! $23.96M |
Open | High | Low | Value | Volume |
8.7¢ | 8.7¢ | 8.1¢ | $50.65K | 608.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 131400 | 8.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.6¢ | 7168 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 131400 | 0.082 |
2 | 170000 | 0.081 |
2 | 200000 | 0.080 |
1 | 15000 | 0.078 |
1 | 14091 | 0.077 |
Price($) | Vol. | No. |
---|---|---|
0.086 | 7168 | 1 |
0.091 | 10989 | 1 |
0.093 | 37410 | 1 |
0.095 | 54200 | 2 |
0.096 | 35000 | 1 |
Last trade - 16.10pm 16/08/2024 (20 minute delay) ? |
Featured News
NOX (ASX) Chart |